Knight Therapeutics, Inc. (GUD.TO)
10.83
+0.10
(+0.93%)
CAD |
TSX |
Oct 09, 16:00
Knight Therapeutics Price to Book Value : 1.332 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.332 |
| October 08, 2026 | 1.320 |
| October 07, 2026 | 1.317 |
| October 06, 2026 | 1.296 |
| October 05, 2026 | 1.274 |
| October 02, 2026 | 1.269 |
| October 01, 2026 | 1.309 |
| September 30, 2026 | 1.302 |
| September 29, 2026 | 1.273 |
| September 28, 2026 | 1.263 |
| September 25, 2026 | 1.266 |
| September 24, 2026 | 1.242 |
| September 23, 2026 | 1.241 |
| September 22, 2026 | 1.266 |
| September 21, 2026 | 1.252 |
| September 18, 2026 | 1.261 |
| September 17, 2026 | 1.258 |
| September 16, 2026 | 1.231 |
| September 15, 2026 | 1.225 |
| September 14, 2026 | 1.232 |
| September 11, 2026 | 1.212 |
| September 10, 2026 | 1.197 |
| September 09, 2026 | 1.218 |
| September 08, 2026 | 1.218 |
| September 04, 2026 | 1.231 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.235 |
| September 02, 2026 | 1.189 |
| September 01, 2026 | 1.186 |
| August 31, 2026 | 1.188 |
| August 28, 2026 | 1.165 |
| August 27, 2026 | 1.180 |
| August 26, 2026 | 1.200 |
| August 25, 2026 | 1.199 |
| August 24, 2026 | 1.188 |
| August 21, 2026 | 1.188 |
| August 20, 2026 | 1.184 |
| August 19, 2026 | 1.208 |
| August 18, 2026 | 1.197 |
| August 17, 2026 | 1.203 |
| August 14, 2026 | 1.146 |
| August 13, 2026 | 1.133 |
| August 12, 2026 | 1.143 |
| August 11, 2026 | 1.168 |
| August 10, 2026 | 1.145 |
| August 07, 2026 | 1.200 |
| August 06, 2026 | 1.168 |
| August 05, 2026 | 1.139 |
| August 04, 2026 | 1.149 |
| July 31, 2026 | 1.210 |
| July 30, 2026 | 1.202 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| HLS Therapeutics, Inc. | 1.632 |
| Bausch Health Cos., Inc. | -- |
| Cipher Pharmaceuticals, Inc. | 1.782 |
| BioSyent, Inc. | 4.242 |
| Revive Therapeutics Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 72.10 |
| PS Ratio | 1.959 |
| PEG Ratio | 0.0157 |
| Price to Free Cash Flow | 10.83 |
| Price | 10.83 |
| Earnings Yield | 1.39% |
| Market Cap | 1.064B |
| PEGY Ratio | 0.0157 |
| Operating PE Ratio | 40.62 |
| Normalized PE Ratio | 53.46 |